Abstract
Amide proton transfer (APT) imaging is a new molecular MRI technique that detects endogenous mobile proteins and peptides in tissue. In this Chapter, the preclinical studies and pilot clinical data in brain tumor imaging are reviewed. APT imaging provides unique information regarding the presence and grade of brain tumors at the protein and peptide level. It has the potential to enhance the noninvasive detection and characterization of brain cancers before and after treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsREFERENCES
Aime, S., Barge, A., Delli Castelli, D., Fedeli, F., Mortillaro, A., Nielsen, F.U., and Terreno, E. (2002) Paramagnetic Lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn. Reson. Med. 47:639–648
Aime, S., Carrera, C., Delli Castelli, D., Geninatti Crich, S., and Terreno, E. (2005) Tunable imaging of cells labelled with MRI-PARACEST agents. Angew. Chem. Int. Ed. 44:1813–1815
Albert, F.K., Forsting, M., Sartor, K., Adams, H.-P., and Kunze, S. (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45–60
Balaban, R.S., and Ceckler, T.L. (1992) Magnetization transfer contrast in magnetic resonance imaging. Magn. Reson. Q. 8:116–137
Burger, P.C., Heinz, E.R., Shibata, T., and Kleihues, P. (1988) Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J. Neurosurg. 68:698–704
Chenevert, T.L., McKeever, P.E., and Ross, B.D. (1997) Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin. Cancer Res. 3:1457–1466
Ersoy, H., and Rybicki, F.J. (2007) Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J. Magn. Reson. Imaging 26:1190–1197
Gauvain, K.M., McKinstry, R.C., Mukherjee, P., Perry, A., Neil, J.J., Kaufman, B.A., and Hayashi, R.J. (2001) Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. Am. J. Roentgenol. 177:449–454
Gilad, A.A., McMahon, M.T., Walczak, P., Winnard, P.T., Raman, V., van Laarhoven, H.W.M., Skoglund, C.M., Bulte, J.W.M., and van Zijl, P.C.M. (2007) Artificial reporter gene providing MRI contrast based on proton exchange. Nature Biot. 25:217–219
Gillies, R.J., Bhujwalla, Z., Evelhoch, J., Garwood, M., Neeman, M., Robinson, S.P., Sotak, C.H., and van der Sanden, B. (2000) Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia 2:139–151
Goffeney, N., Bulte, J.W.M., Duyn, J., Bryant, L.H., and van Zijl, P.C.M. (2001) Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. J. Am. Chem. Soc. 123:8628–8629
Hobbs, S.K., Shi, G., Homer, R., Harsh, G., Altlas, S.W., and Bednarski, M.D. (2003) Magnetic resonance imaging-guided proteomics of human glioblastoma multiforme. J. Magn. Reson. Imaging 18:530–536
Howe, F.A., Barton, S.J., Cudlip, S.A., Stubbs, M., Saunders, D.E., Murphy, M., Wilkins, P., Opstad, K.S., Doyle, V.L., McLean, M.A., Bell, B.A., and Griffiths, J.R. (2003) Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn. Reson. Med. 49:223–232
Jokivarsi, K.T., Grohn, H.I., Grohn, O.H., and Kauppinen, R.A. (2007) Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia. Magn. Reson. Med. 57:647–653
Jones, C.K., Schlosser, M.J., van Zijl, P.C., Pomper, M.G., Golay, X., and Zhou, J. (2006) Amide proton transfer imaging of human brain tumors at 3T. Magn. Reson. Med. 56:585–592
Kelly, P.J., Daumas-Duport, C., Kispert, D.B., Kall, B.A., Scheithauer, B.W., and Illig, J.J. (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J. Neurosurg. 66:865–874
Knopp, E.A., Cha, S., Johnson, G., Mazumdar, A., Golfinos, J.G., Zagzag, D., Miller, D.C., Kelly, P.J., and Kricheff, I.I. (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791–798
Law, M., Yang, S., Wang, H., Babb, J.S., Johnson, G., Cha, S., Knopp, E.A., and Zagzag, D. (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am. J. Neuroradiol. 24:1989–1998
Ling, W., Regatte, R.R., Navon, G., and Jerschow, A. (2008) Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependnt saturation transfer (gagCEST). Proc. Natl. Acad. Sci. USA 105:2266–2270
Mullins, M.E., Barest, G.D., Schaefer, P.W., Hochberg, F.H., Gonzalez, R.G., and Lev, M.H. (2005) Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am. J. Neuroradiol. 26:1967–1972
Ross, B.D., Higgins, R.J., Boggan, J.E., Knittel, B., and Garwood, M. (1988) 31P NMR spectroscopy of the in vivo metabolism of an intracerebral glioma in the rat. Magn. Reson. Med. 6:403–417
Salhotra, A., Lal, B., Laterra, J., Sun, P.Z., van Zijl, P.C.M., and Zhou, J. (2008) Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed. 21:489–497
Scott, J.N., Brasher, P.M., Sevick, R.J., Rewcastle, N.B., and Forsyth, P.A. (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947–949
Sun, P.Z., Zhou, J., Sun, W., Huang, J., and van Zijl, P.C.M. (2007) Delineating the boundary between the Ischemic Penumbra and regions of Oligaemia using pH-weighted Magnetic Resonance Imaging (pHWI). J. Cereb. Blood Flow Metab. 27:1129–1136
van Zijl, P.C.M., Jones, C.K., Ren, J., Malloy, C.R., and Sherry, A.D. (2007) MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc. Natl. Acad. Sci. USA 104:4359–4364
Vigneron, D., Bollen, A., McDermott, M., Wald, L., Day, M., Moyher-Noworolski, S., Henry, R., Chang, S., Berger, M., Dillon, W., and Nelson, S. (2001) Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn. Reson. Imaging 19:89–101
Ward, K.M., Aletras, A.H., and Balaban, R.S. (2000) A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J. Magn. Reson. 143:79–87
Wolff, S.D., and Balaban, R.S. (1990) NMR imaging of labile proton exchange. J. Magn. Reson. 86:164–169
Yoo, B., and Pagel, M.D. (2006) A PARACEST MRI contrast agent to detect enzyme activity. J. Am. Chem. Soc. 128:14032–14033
Zhang, S., Winter, P., Wu, K., and Sherry, A.D. (2001) A novel europium(III)-based MRI contrast agent. J. Am. Chem. Soc. 123:1517–1578
Zhang, S., Trokowski, R., and Sherry, A.D. (2003) A paramagnetic CEST agent for imaging glucose by MRI. J. Am. Chem. Soc. 125:15288–15289
Zhou, J., Payen, J., Wilson, D.A., Traystman, R.J., and van Zijl, P.C.M. (2003a) Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nature Med. 9:1085–1090
Zhou, J., Lal, B., Wilson, D.A., Laterra, J., and van Zijl, P.C.M. (2003b) Amide proton transfer (APT) contrast for imaging of brain tumors. Magn. Reson. Med. 50:1120–1126
Zhou, J., Wilson, D.A., Sun, P.Z., Klaus, J.A., and van Zijl, P.C.M. (2004) Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn. Reson. Med. 51:945–952
Zhou, J., Blakeley, J.O., Hua, J., Kim, M., Laterra, J., Pomper, M.G., and van Zijl, P.C.M. (2008) Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn. Reson. Med. 60:842–849
Acknowledgments.This work was supported in part by grants from NIH (RR015241 and EB002634) and the Dana Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Netherlands
About this chapter
Cite this chapter
Zhou, J., Blakeley, J.O. (2011). Brain Tumors: Amide Proton Transfer Imaging. In: Hayat, M. (eds) Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy and Prognosis, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8665-5_11
Download citation
DOI: https://doi.org/10.1007/978-90-481-8665-5_11
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-8664-8
Online ISBN: 978-90-481-8665-5
eBook Packages: MedicineMedicine (R0)